Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Haugnes HS"'
Autor:
Oldenburg, J, Aparicio, J, Beyer, J, Cohn-Cedermark, G, Cullen, M, Gilligan, T, De Giorgi, U, De Santis, M, de Wit, R, Fossa, SD, Germa-Lluch, JR, Gillessen, S, Haugnes, HS, Honecker, F, Horwich, A, Lorch, A, Ondrus, D, Rosti, G, Stephenson, AJ, Tandstad, T, SWENOTECA Swedish Norwegian, Italian Germ Cell Canc Grp IGG, Spanish Germ Cell Canc Grp SGCCG
Publikováno v:
ANNALS OF ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Testicular cancer (TC) is the most common neoplasm in males aged 15-40 years. The majority of patients have no evidence of metastases at diagnosis and thus have clinical stage I (CSI) disease [Oldenburg J, Fossa SD, Nuver J et al. Testicular seminoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9ec97dcd529d8b99d1a77ddacc31f789
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8928
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8928
Autor:
Thor A; Division of Urology, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Myklebust MP; Mohn Cancer Research Laboratory, Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway., Grenabo Bergdahl A; Department of Urology, Gothenburg University, Gothenburg, Sweden.; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden., Lundgren PO; Division of Urology, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Skokic V; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Almås B; Department of Urology, Haukeland University Hospital, Bergen, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, UIT-The Arctic University of Norway, Tromsø, Norway., Tandstad T; The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Akre O; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Cohn-Cedermark G; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden., Dahl O; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, Medical Faculty, University of Bergen, Norway., Kjellman A; Division of Urology, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
The Journal of urology [J Urol] 2024 Nov; Vol. 212 (5), pp. 720-730. Date of Electronic Publication: 2024 Jul 25.
Autor:
Sundset R; PET-senteret, Universitetssykehuset Nord-Norge, og, Nukleærmedisinsk og strålebiologisk forskningsgruppe, UiT - Norges arktiske universitet., Haugnes HS; Kreftavdelingen, Universitetssykehuset Nord-Norge, og, UiT - Norges arktiske universitet., Perez A; PET-senteret, Universitetssykehuset Nord-Norge., Engelsen O; PET-senteret, Universitetssykehuset Nord-Norge., Fosseide IHH; PET-senteret, Universitetssykehuset Nord-Norge., Castillejo MJ; PET-senteret, Universitetssykehuset Nord-Norge., Bogsrud TV; PET-senteret, Universitetssykehuset Nord-Norge, og, Nuklearmedicin og PET, Aarhus Universitetshospital.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Jul 30; Vol. 144 (9). Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024).
Autor:
Thor A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Negaard HFS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Grenabo Bergdahl A; Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden., Almås B; Department of Urology, Haukeland University Hospital, Bergen, Norway., Melsen Larsen S; Department of Urology, Oslo University Hospital, Oslo, Norway., Lundgren PO; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Gerdtsson A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Institution of Translational Medicine, Lund University, Malmö, Sweden., Halvorsen D; Department of Urology, St. Olavs University Hospital, Trondheim, Norway., Johannsdottir B; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden., Jansson AK; Department of Immunology, Genetics & Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden., Hellström M; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Wahlqvist R; Department of Urology, Oslo University Hospital, Oslo, Norway., Langberg CW; The Cancer Centre, Oslo University Hospital, Oslo, Norway., Hedlund A; Department of Oncology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden., Akre O; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Glimelius I; Department of Immunology, Genetics & Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden., Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, UIT - The Arctic University of Norway, Tromsø, Norway., Cohn-Cedermark G; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology - Pathology, Karolinska Institute, Stockholm, Sweden., Kjellman A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institute, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Tandstad T; The Cancer Clinic, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Publikováno v:
European urology open science [Eur Urol Open Sci] 2024 Jun 11; Vol. 65, pp. 13-19. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).
Autor:
Löffeler S; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Bertilsson H; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Urology, St. Olav's University Hospital, Trondheim, Norway., Müller C; Department of Oncology, Sørlandet Hospital Trust, Kristiansand, Norway., Aas K; Department of Urology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, The Arctic University of Norway (UIT), Tromsø, Norway., Aksnessæther B; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund, Norway., Pesonen M; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Thon K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Tandstad T; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Oncology, The Cancer Clinic, St Olav's University Hospital, Trondheim, Norway., Murtola T; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Urology, Tampere University Hospital, Tampere, Finland., Poulsen MH; Department of Urology, Odense University Hospital, Odense, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Nordstrøm T; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Vigmostad MN; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Ottosson F; Department of Urology, Oslo University Hospital, Oslo, Norway., Holmsten K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Capio St. Göran Hospital, Stockholm, Sweden., Christiansen O; Department of Urology, Innlandet Hospital Trust, Hamar, Norway., Slaaen M; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Research Centre for Age-Related Functional Decline and Disease, Innlandet Hospital Trust, Ottestad, Norway., Haug ES; Department of Urology, Vestfold Hospital Trust, Tønsberg, Norway., Storås AH; Department of Oncology, Oslo University Hospital, Oslo, Norway., Asphaug L; Institute of Health and Society, University of Oslo, Oslo, Norway.; Clinical Trials Unit, Oslo University Hospital, Oslo, Norway., Rannikko A; Department of Urology and Research Program in Systems Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Brasso K; Copenhagen Prostate Cancer Center, Department of Urology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
BJU international [BJU Int] 2024 Jun; Vol. 133 (6), pp. 680-689. Date of Electronic Publication: 2024 Mar 12.
Autor:
Gerdtsson A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Negaard HFS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Almås B; Department of Urology, Haukeland University Hospital, Bergen, Norway., Bergdahl AG; Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenborg, Sweden., Cohn-Cedermark G; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden., Glimelius I; Department of Immunology, Genetics and Pathology, Cancer Precision Medicine, Uppsala University, Uppsala, Sweden., Halvorsen D; Department of Urology, St. Olavs University Hospital, Trondheim, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Department of Clinical Medicine, UIT- The Arctic University of Norway, Tromsø, Norway., Hedlund A; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Hellström M; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Holmberg G; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenborg, Sweden., Karlsdóttir Á; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Kjellman A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Larsen SM; Department of Urology, Oslo University Hospital, Oslo, Norway., Thor A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden.; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden., Wahlqvist R; Department of Urology, Oslo University Hospital, Oslo, Norway., Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Clinical Sciences, Lund University, Lund, Sweden., Tandstad T; The Cancer Clinic, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
Publikováno v:
BJU international [BJU Int] 2024 Jun; Vol. 133 (6), pp. 717-724. Date of Electronic Publication: 2024 Jan 31.
Autor:
Støyten M; Institute of Clinical Medicine, UIT - The Arctic University, Tromsø, Norway., Knutsen T; Department of Urology, University Hospital of North Norway, Tromsø, Norway., Stikbakke E; Institute of Clinical Medicine, UIT - The Arctic University, Tromsø, Norway; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Agledahl I; Department of Urology, University Hospital of North Norway, Tromsø, Norway., Wilsgaard T; Institute of Community Medicine, UIT-The Arctic University, Tromsø, Norway., Eggen AE; Institute of Community Medicine, UIT-The Arctic University, Tromsø, Norway., Richardsen E; Department of Pathology, University Hospital of North Norway, Tromsø, Norway; Department of Medical Biology, UIT - The Arctic University, Tromsø, Norway., Giovannucci E; Departments of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Thune I; Institute of Clinical Medicine, UIT - The Arctic University, Tromsø, Norway; Insitute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Oncology, Oslo University Hospital, Norway., Haugnes HS; Institute of Clinical Medicine, UIT - The Arctic University, Tromsø, Norway; Department of Oncology, University Hospital of North Norway, Tromsø, Norway. hege.sagstuen.haugnes@uit.no.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Apr 09; Vol. 63, pp. 154-163. Date of Electronic Publication: 2024 Apr 09.
Autor:
Fosså SD; Department of Oncology, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo. Electronic address: s.d.fossa@medisin.uio.no., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø; Department of Clinical Medicine, UiT, The Arctic University, Tromsø., Dahl AA; Department of Oncology, Oslo University Hospital, Oslo., Kiserud CE; Department of Oncology, Oslo University Hospital, Oslo., Fosså A; Department of Oncology, Oslo University Hospital, Oslo., Skalleberg J; Department of Otolaryngology, Head and Neck Surgery, Oslo University Hospital, Oslo., Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Dec; Vol. 34 (12), pp. 1165-1174. Date of Electronic Publication: 2023 Sep 21.
Autor:
Upreti RP; Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway., Mmbaga E; Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, UIT- The Arctic University, Tromsø, Norway., Kiserud CE; Department of Oncology, Oslo University Hospital, Oslo, Norway., Del Risco Kollerud R; Department of rehabilitation, National Advisory Unit on Occupational Rehabilitation, Rauland, Norway.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1607-1615. Date of Electronic Publication: 2023 Nov 25.
Autor:
Thorsen L; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Department of Clinical Service, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Courneya KS; Faculty of Kinesiology, Sport and Recreation, University of Alberta, Edmonton, Canada., Steene-Johannessen J; Department of Sports Medicine, Norwegian School of Sports Sciences, Oslo, Norway., Gran JM; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Haugnes HS; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.; Institute of Clinical Medicine, University of Tromsø - The Arctic University, Tromsø, Norway., Negaard HFS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Kiserud CE; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Fosså SD; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Oct 15; Vol. 153 (8), pp. 1512-1519. Date of Electronic Publication: 2023 Jun 19.